Prospective, randomized comparison in humans of a unipolar defibrillation system with that using an additional superior vena cava electrode.
- 1 March 1994
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 89 (3) , 1090-1093
- https://doi.org/10.1161/01.cir.89.3.1090
Abstract
BACKGROUND A unipolar defibrillation system using a single right ventricular (RV) electrode and the active shell or "CAN" of the implantable cardioverter-defibrillator itself situated in a left infraclavicular pocket has been shown to be as efficient in defibrillation as an epicardial lead system. The purpose of this study was to determine whether defibrillation efficacy can be improved further by adding a superior vena cava (SVC) electrode to this already efficient defibrillation system. METHODS AND RESULTS We prospectively and randomly compared the defibrillation efficacy of a simplified unipolar defibrillation system, RV-->CAN, with that of one incorporating a high SVC electrode, RV-->SVC + CAN, in 15 consecutive cardiac arrest survivors undergoing implantation of a presently available transvenous defibrillation system. The RV defibrillation electrode was a 5-cm coil located on a 10.5F lead used as the anode in both lead configurations examined. The active CAN was a 108-cm2 surface area shell of a titanium alloy pulse generator used as the cathode in both configurations and placed in a left infraclavicular pocket. The SVC electrode was a 6F 5-cm-long coil and was used as an additional cathode positioned at the junction of the SVC and the left innominate vein. The defibrillation pulse used was a 65% tilt, asymmetric biphasic waveform delivered from a 120-microF capacitor. The defibrillation threshold (DFT) stored energy, leading edge voltage, current, and pulsing resistance were measured for both lead systems. The single-lead unipolar system, RV-->CAN, resulted in a stored energy DFT of 7.4 +/- 5.2 J, and the three-electrode dual pathway system, RV-->SVC + CAN, resulted in a DFT of 6.0 +/- 3.4 J (P = .20). There was no difference in defibrillation efficacy with the more complicated three-electrode system over the unipolar system despite a decrease in pulsing resistance to 48.6 +/- 3.5 omega compared with 61.2 +/- 5.9 omega for the unipolar system (P < .0001) and a slight rise in delivered current to 6.3 +/- 1.8 A compared with 5.5 +/- 2.0 A for the unipolar system (P = .062). CONCLUSIONS The unipolar single-lead transvenous defibrillation system provides defibrillation at energy levels comparable to that reported with present epicardial lead systems. Coupling of this lead system to a third SVC electrode increases system complexity but offers little defibrillation advantage despite a large decrease in pulsing resistance and a modest increase in delivered current.Keywords
This publication has 17 references indexed in Scilit:
- Current Concepts for Selecting the Location, Size and Shape of Defibrillation ElectrodesPacing and Clinical Electrophysiology, 1991
- An effective and adaptable transvenous defibrillation system using the coronary sinus in humansJournal of the American College of Cardiology, 1990
- Efficacy of the automatic implantable cardioverter-defibrillator in prolonging survival in patients with severe underlying cardiac diseaseJournal of the American College of Cardiology, 1990
- Clinical experience in seventy-seven patients with the automatic implantable cardioverter defibrillatorAmerican Heart Journal, 1989
- A prospective randomized evaluation of biphasic versus monophasic waveform pulses on defibrillation efficacy in humansJournal of the American College of Cardiology, 1989
- Prospective comparison of sequential pulse and single pulse defibrillation with use of two different clinically available systemsJournal of the American College of Cardiology, 1989
- Evaluation of electrode polarity on defibrillation efficacyThe American Journal of Cardiology, 1989
- Improved low energy defibrillation efficacy in man with the use of a biphasic truncated exponential waveformAmerican Heart Journal, 1989
- The automatic implantable cardioverter defibrillator as antiarrhythmic treatment modality of choice for survivors of cardiac arrest unrelated to acute myocardial infarctionThe American Journal of Cardiology, 1988
- The automatic implantable cardioverter defibrillator: Efficacy, complications and survival in patients with malignant ventricular arrhythmiasJournal of the American College of Cardiology, 1988